Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure
1 Centro Studi ANMCO, Firenze, Italy
2 Policlinico S. Matteo, Pavia, Italy
3 Consorzio Mario Negri Sud Santa Maria Imbaro, Italy
4 Istituto di Ricerche Farmacoligiche Mario Negri, Milano, Italy
5 Ospedale Civile Desio, Milano, Italy
* Correspondence: Aldo Pietro Maggioni, Centro Studi ANMCO, Via La Marmora, Firenze, Italy.
Key Words: n-3 PUFA arrhythmias primary prevention congestive heart failure
References
- GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447455[CrossRef][Web of Science][Medline]
- Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 19851990. Circulation. 1997;96:38493859
[Abstract/Free Full Text] - Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:13491355
[Abstract/Free Full Text] - CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:913[CrossRef][Web of Science][Medline]
- MERIT-HF Study Group. Effects of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure. (MERIT-HF). J Am Med Assoc. 2000;283:12951302
- Zannad PB, Remme WJ, Cody R, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med. 1999;341:709717
[Abstract/Free Full Text] - Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;357:8995[CrossRef][Web of Science][Medline]
- Opasich C, Tavazzi L, Lucci D, et al. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol. 2000;86:353357[CrossRef][Web of Science][Medline]
- Marchioli R, Avanzini A, Barzi F, et al, GISSI-Prevenzione Investigators. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factors assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J. 2001;: (in press)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||